CLAIRE MANN: Open Payments
NPI 1427520469 · FRISCO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 21 payments from 12 companies in 2025. Trend: 2023 $378 · 2024 $497 · 2025 $587
Food & beverage: $487Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $156 |
| Janssen Biotech, Inc. | 3 | $149 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| Lilly USA, LLC | 2 | $44 |
| GENZYME CORPORATION | 1 | $28 |
| UCB, Inc. | 1 | $25 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $23 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $23 |
| Botanix SB Inc | 1 | $18 |
| Incyte Corporation | 1 | $18 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, BOTOX, EBGLYSS, Bimzelx, Cabtreo, SOFDRA.
Industry payments across CO — which companies pay providers there.
